期刊文献+

多发性骨髓瘤继发心肌淀粉样变性1例并文献复习

收藏 分享 导出
摘要 目的报道1例多发性骨髓瘤(MM)继发心肌淀粉样变性患者3. 5年的诊治过程,总结治疗经验及获益。方法对本例患者的临床资料进行分析,并结合相关文献进行复习。结果本例临床获益:(1)诊断早;(2)硼替佐米采用皮下注射方式,3. 5年无周围神经系统不良反应;(3)治疗后血清游离轻链比率正常化且出现异常蛋白条带,提示预后良好;(4)淀粉样变性器官功能改善明显,延长了生存期。结论 MM继发心脏淀粉样变性,若能早期诊断和迅速进行"源头治疗",亦能获得非常好的血液学缓解及器官功能改善,进而延长生存期。
出处 《中国临床研究》 CAS 2019年第1期97-99,共3页 Chinese Journal of Clinical Research
  • 相关文献

参考文献4

二级参考文献64

  • 1Moreau P, Pylypenko H, Grosicki S, et al. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non- inferiority study. Lancet Oncol, 2011, 12: 431-440. 被引量:1
  • 2Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med, 2004, 351: 1860-1873. 被引量:1
  • 3Richardson PG, Sonneveld P, Schuster M, et al. Extended follow- up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood, 2007, 110: 3557-3560. 被引量:1
  • 4Pineda-Roman M, Zangari M, van Rhee F, et al. VTD combination therapy with bortezomib- thalidomide- dexamethasone is highly effective in advanced and refractory multiple myeloma. Leukemia, 2008, 22: 1419-1427. 被引量:1
  • 5Hideshma T, Richard son P, Chanhan D, et al.The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res, 2001, 61: 3071-3076. 被引量:1
  • 6Jagannath S, Richardson PG, Barlogie B, et al.Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone. Haematologica, 2006, 91: 929-934. 被引量:1
  • 7Ynan ZG, Jin J, Huang XJ, et al. Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma: an open-label, observational, multi-center study in China. Chin Med J(Engl), 2011,124: 2969-2974. 被引量:1
  • 8Ludwig H, Beksac M, Blade J, et al. Current multiple myeloma treatment strategies with novel agents: a European perspective. Oncologist, 2010, 15: 6-25. 被引量:1
  • 9Harousseau JL, Attal M, Avet-Loiseau H. The role of complete response in multiple myeloma. Blood, 2009, 114:3139-3146. Mateos MV, Hernandez JM, Hernandez MT, et al. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study. Blood, 2006, 108: 2165-2172. 被引量:1
  • 10Mateos MV, Hemandez JM, Hemandez MT, et al. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study. Blood, 2006, 108: 2165-2172. 被引量:1

共引文献117

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈